Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 380 (110th)

Pharmaceutical Market Access and Drug Safety Act of 2007

referredUnited States· United States Congress· EN

Introduced

10 January 2007

Last action

2 February 2007 · Referred

Status

Referred to the Subcommittee on Commerce, Trade and Consumer Protection.

Sponsors

Rep. Emanuel, Rahm [D-IL-5], Rep. Emerson, Jo Ann [R-MO-8], Rep. Simpson, Michael K. [R-ID-2], Rep. Kildee, Dale E. [D-MI-5], Rep. Taylor, Gene [D-MS-4], Rep. Carson, Julia [D-IN-7], Rep. Weiner, Anthony D. [D-NY-9], Rep. Larsen, Rick [D-WA-2], Rep. Berry, Marion [D-AR-1], Rep. DeLauro, Rosa L. [D-CT-3], Rep. Costa, Jim [D-CA-21], Rep. McCollum, Betty [D-MN-4], Rep. Marshall, Jim [D-GA-8], Rep. Wamp, Zach [R-TN-3], Rep. DeFazio, Peter A. [D-OR-4], Rep. Ramstad, Jim [R-MN-3], Rep. Ruppersberger, C. A. Dutch [D-MD-2], Rep. Lowey, Nita M. [D-NY-17], Rep. Israel, Steve [D-NY-3], Rep. McNulty, Michael R. [D-NY-23], Rep. Cooper, Jim [D-TN-5], Rep. Burton, Dan [R-IN-5], Rep. Costello, Jerry F. [D-IL-12], Rep. Murtha, John P. [D-PA-12], Rep. Gutierrez, Luis V. [D-IL-4], Rep. Cummings, Elijah E. [D-MD-7], Rep. Oberstar, James L. [D-MN-8], Rep. Moore, Dennis [D-KS-3], Rep. Green, Gene [D-TX-29], Rep. Hoekstra, Peter [R-MI-2], Rep. Frank, Barney [D-MA-4], Rep. Musgrave, Marilyn N. [R-CO-4], Rep. Hinchey, Maurice D. [D-NY-22], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Hastings, Alcee L. [D-FL-20], Rep. Bishop, Timothy H. [D-NY-1], Rep. Shays, Christopher [R-CT-4], Rep. Kanjorski, Paul E. [D-PA-11], Rep. Tierney, John F. [D-MA-6], Rep. LaTourette, Steven C. [R-OH-14], Rep. Carnahan, Russ [D-MO-3], Rep. Cleaver, Emanuel [D-MO-5], Rep. Platts, Todd Russell [R-PA-19], Sen. Van Hollen, Chris [D-MD], Rep. Chandler, Ben [D-KY-6], Rep. Wynn, Albert Russell [D-MD-4], Rep. Holden, Tim [D-PA-17], Rep. Ackerman, Gary L. [D-NY-5]

Subjects

Healthcare

Source updated

10 January 2026

Healthcare

Official sourceDownload fileView documentsShare

Summary

Pharmaceutical Market Access and Drug Safety Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States. Prohibits the importation of a qualifying drug unless such drug is imported by: (1) a registered importer; or (2) an individual for personal use. Establishes registration conditions for importers and exporters. Requires the Secretary to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions. Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences. Prohibits manufacturers from: (1) discriminating against registered exporters or importers; (2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country; (3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or (4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug. States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement. Requires the Secretary to educate consumers regarding prescription drug importation. Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA. Prohibits the introduction of restricted transactions with unregistered foreign pharmacies into a payment system or the completion of such transactions using a payment system.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 10 January 2007

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 10 January 2007

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 10 January 2007

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 2 February 2007

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 10 January 2007

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 10 January 2007

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 10 January 2007

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 111 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.